Clinical breakpoints for voriconazole and Candida spp. revisited: Review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria

Michael A. Pfaller, David Andes, Maiken C. Arendrup, Daniel J. Diekema, Ana Espinel-Ingroff, Barbara D. Alexander, Steven D. Brown, Vishnu Chaturvedi, Cynthia L. Fowler, Mahmoud A. Ghannoum, Elizabeth M. Johnson, Cynthia C. Knapp, Mary R. Motyl, Luis Ostrosky-Zeichner, Thomas J. Walsh

Research output: Contribution to journal › Article › peer-review

98 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical breakpoints for voriconazole and Candida spp. revisited: Review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria'. Together they form a unique fingerprint.

Medicine & Life Sciences